MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
2.000
+0.060 (3.09%)
Sep 5, 2025, 4:00 PM - Market closed
MacroGenics Employees
MacroGenics had 341 employees as of December 31, 2024. The number of employees increased by 2 or 0.59% compared to the previous year.
Employees
341
Change (1Y)
2
Growth (1Y)
0.59%
Revenue / Employee
$485,323
Profits / Employee
-$106,742
Market Cap
126.41M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 341 | 2 | 0.59% |
Dec 31, 2023 | 339 | -18 | -5.04% |
Dec 31, 2022 | 357 | -70 | -16.39% |
Dec 31, 2021 | 427 | 57 | 15.41% |
Dec 31, 2020 | 370 | -14 | -3.65% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MGNX News
- 4 days ago - MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 23 days ago - MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities - GlobeNewsWire
- 24 days ago - MacroGenics Appoints Eric Risser as President and Chief Executive Officer - GlobeNewsWire
- 3 months ago - MacroGenics: Working On That Road To Recovery - Seeking Alpha
- 3 months ago - MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement - GlobeNewsWire
- 3 months ago - MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - GlobeNewsWire
- 4 months ago - MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - MacroGenics Announces Date of First Quarter 2025 Financial Results - GlobeNewsWire